# Parenteral Ascorbic Acid Repletion in TransplantatIon

> **NCT04756063** · PHASE4 · SUSPENDED · sponsor: **University of Wisconsin, Madison** · enrollment: 90 (estimated)

## Conditions studied

- Liver Transplant Failure and Rejection

## Interventions

- **DRUG:** Ascorbic acid
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT04756063
- **Lead sponsor:** University of Wisconsin, Madison
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** SUSPENDED
- **Start date:** 2026-05
- **Primary completion:** 2031-03
- **Final completion:** 2032-03
- **Target enrollment:** 90 (ESTIMATED)
- **Why stopped:** Resources
- **Last updated:** 2026-04-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04756063

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04756063, "Parenteral Ascorbic Acid Repletion in TransplantatIon". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT04756063. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*